Yes, especially in the EU, where TiO₂ is under review for pharmaceuticals. Moreover, it demonstrates proactive compliance and reduces the risk of reformulation later.
Yes, especially in the EU, where TiO₂ is under review for pharmaceuticals. Moreover, it demonstrates proactive compliance and reduces the risk of reformulation later.